|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the US Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center at the University of California, Davis, CA (CBS); the Department of Nutrition, University of California, Davis, CA (CBS); the Department of Food Science and Human Nutrition, Iowa State University, Ames, IA (GSM and LAK); the Division of Allergy and Immunology, Joseph Stokes Jr Research Institute at The Children's Hospital of Pennsylvania, Philadelphia, PA (SDD); the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA (SDD); the Saban Research Institute at the Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA (GMA); and the Department of Pediatrics and Medicine, University of Alabama at Birmingham, Birmingham, AL (CMW)
Background: Vitamin D status affects immune function and thus may affect the progress of HIV infection.
Objectives: Our goals were to assess vitamin D intake and status in subjects with HIV infection and in matched control subjects and to determine whether HIV infection was associated with vitamin D insufficiency.
Design: Plasma 25-hydroxyvitamin D [25(OH)D] concentrations and vitamin D intake were measured in a cross-sectional study of members of the Reaching for Excellence in Adolescent Health (REACH) cohort.
Results: The subjects were aged 1423 y; 74% were female, and 72% were black. Mean (±SE) vitamin D intake from food was 30% greater (P = 0.023) in HIV-positive subjects (295 ± 18 IU/d; n = 237) than in HIV-negative subjects (227 ± 26 IU/d; n = 121). The prevalence of vitamin D supplement use was 29% (104 of 358 subjects) and did not differ significantly by HIV status (P = 0.87). Mean plasma 25(OH)D did not differ significantly (P = 0.62) between the HIV-positive (20.3 ± 1.1 nmol/L; n = 238) and HIV-negative (19.3 ± 1.7 nmol/L; n = 121) subjects, nor was HIV status a significant predictor of plasma 25(OH)D when multiple regression analysis was used to adjust for other variables. The prevalence of vitamin D insufficiency [plasma 25(OH)D
37.5 nmol/L] in the subjects was 87% (312 of 359 subjects).
Conclusions: HIV infection did not influence vitamin D status. The prevalence of vitamin D insufficiency in both HIV-positive and HIV-negative REACH subjects was high, perhaps because these disadvantaged, largely urban youth have limited sun exposure.
Key Words: Vitamin D HIV infection dietary intake adolescents race
This article has been cited by other articles:
![]() |
S. M. Arpadi, D. McMahon, E. J. Abrams, M. Bamji, M. Purswani, E. S. Engelson, M. Horlick, and E. Shane Effect of Bimonthly Supplementation With Oral Cholecalciferol on Serum 25-Hydroxyvitamin D Concentrations in HIV-Infected Children and Adolescents Pediatrics, January 1, 2009; 123(1): e121 - e126. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |